Category Archives: Biotech

San Diego – Based Illumina Hires Dr. Alex Aravanis as CTO

San Diego – Based Illumina Hires Dr. Alex Aravanis as CTO

Dr. Alex Aravanis, Illumina’s New CTO

Illumina recently announced they have signed on Dr. Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic. Dr. Aravanis will join Illumina in early June and will report to Chief Executive Officer, Francis deSouza.

Continue Reading
San Diego-based Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands  Capability for COVID-19 Surveillance

San Diego-based Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands Capability for COVID-19 Surveillance

San Diego-based Illumina, Inc. has announced that the African Union Commission, on behalf of the Africa Center for Disease Control and Prevention (CDC), is receiving a $1.4 million donation of our sequencing systems and related consumables intended to expand SARS-CoV-2 sequencing capabilities and capacity in ten African countries, including the Democratic Republic of the Congo,… Continue Reading

San Diego Biotech Plexium Launches w $28 Million

San Diego-based today announced the launch of the company with the closing of a $28 million Series A financing. The financing was led by DCVC Bio and The Column Group, with participation from M Ventures, CRV, and Neotribe Ventures. The company’s proprietary platform, DELPhe, enables cell-based phenotypic screening of DNA-encoded libraries in nanoliter volumes. Continue Reading

Maravai Expands TriLink BioTech Operation

Maravai LifeSciences, providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, recently announced plans to relocate and expand its TriLink BioTechnologies operations with the signing of a lease on a new facility in the Sorrento Valley area of San Diego. Maravai Expands TriLink BioTech Operation TriLink will consolidate its San Diego facilities into a… Continue Reading

Science Exchange-Reveal Biosciences AI Pathology Collaboration

Science Exchange, the leading marketplace for outsourced R&D™, announces a collaboration with Reveal Biosciences to offer on-demand access to AI-based pathology services worldwide. Science Exchange-Reveal Biosciences AI Pathology Collaboration Reveal Biosciences is a San Diego-based company that’s leading the next generation of quantitative histopathology, combining the latest artificial intelligence (AI) techniques with high-quality histology, immunohistochemistry… Continue Reading

Chronic Inflammatory Diseases New Drug Discovery

Chronic Inflammatory Diseases New Drug Discovery for. Blocking the CMPK2 enzyme may result in new treatments for osteoarthritis, Alzheimer’s disease, Parkinson’s disease, lung cancer and more chronic inflammation disease. Chronic Inflammatory Diseases New Drug Discovery Chronic Inflammatory Diseases, inflammation can lead to cancer, Alzheimer’s disease and other conditions. Inflammasomes — protein-based molecular machines — trigger inflammation in… Continue Reading

California’s Life Science Industry Generates Almost $317 Billion Annually, Supports More Than 1.1 Million Jobs

Life science companies in California together generate nearly $317 billion in annual economic output, boost the state’s total gross product by $171.4 billion, support more than 1.1 million jobs and increase labor income by $92 billion per year. These are among the key findings of Biocom’s 2017 Economic Impact Report Databook, which sizes up the… Continue Reading

Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M

San Diego-based Forge Therapeutics, Inc., a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, recently announced a significant collaboration with CARB-X, (Combating Antibiotic Resistant Bacteria Accelerator), the world’s largest public-private partnership focused on funding the advancement of Gram-negative antibiotics. CARB-X selected Forge from a group of 168 international companies and research groups to… Continue Reading